- Home
- Advocacy
- Latest News and Practice Data
- NIH indirect cost cap blocked as administration declines appeal
The Trump administration will not appeal a court ruling that blocks the 2025 proposed policy to cap National Institutes of Health (NIH) indirect cost rates at 15%.
Impact: The decision preserves current NIH funding structures, avoiding cuts included in the NIH policy that raised concerns for pathologists and the broader research community.
What’s next: Any changes to NIH indirect cost funding would now need to move through Congress.
- While the administration did not appeal the case, the President included the administration’s 15% cap in the 2027 budget proposal.
- The CAP has opposed the 15% cap.